Parasitology Research

, Volume 90, Supplement 2, pp S71–S76

Fosmidomycin for the treatment of malaria

Original Paper


In malaria parasites, isoprenoids are synthesised by the mevalonate independent 1-deoxy-D-xylulose 5-phosphate (DOXP) pathway. Fosmidomycin, a natural antibiotic originally developed for the treatment of bacterial infections, represents an inhibitor of DOXP reductoisomerase, an essential enzyme of this pathway. In recent clinical studies it was shown that fosmidomycin is effective in curing uncomplicated Plasmodiumfalciparum malaria in humans. The treatment was well tolerated and resulted in a fast parasite and fever clearance. However, the high rate of recrudescence precludes the use of fosmidomycin as a monotherapy. In drug combination studies, synergy of fosmidomycin with clindamycin was observed. Clinical studies with a fosmidomycin-clindamycin combination are currently ongoing.


  1. Altincicek B, Kollas AK, Sanderbrand S, Wiesner J, Hintz M, Beck E, Jomaa H (2001a) GcpE is involved in the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. J Bacteriol 183:2411–2416Google Scholar
  2. Altincicek B, Kollas A, Eberl M, Wiesner J, Sanderbrand S, Hintz M, Beck E, Jomaa H (2001b) LytB, a novel gene of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. FEBS Lett 499:37–40Google Scholar
  3. Beytia ED, Porter JW (1976) Biochemistry of polyisoprenoid biosynthesis. Annu Rev Biochem 45:113–142Google Scholar
  4. Chakrabarti D, Azam T, DelVecchio C, Qiu L, Park YI, Allen CM (1998) Protein prenyl transferase activities of Plasmodium falciparum. Mol Biochem Parasitol 94:175–184Google Scholar
  5. Couto AS, Kimura EA, Peres VJ, Uhrig ML, Katzin AM (1999) Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units. Biochem J 341:629–637Google Scholar
  6. De Macedo CS, Uhrig ML, Kimura EA, Katzin AM (2002) Characterization of the isoprenoid chain of coenzyme Q in Plasmodium falciparum. FEMS Microbiol Lett 207:13–20Google Scholar
  7. Disch A, Schwender J, Muller C, Lichtenthaler HK, Rohmer M (1998) Distribution of the mevalonate and glyceraldehyde phosphate/pyruvate pathways for isoprenoid biosynthesis in unicellular algae and the cyanobacterium Synechocystis PCC 6714. Biochem J 333:381–388Google Scholar
  8. Dumas R, Biou V, Halgand F, Douce R, Duggleby RG (2001) Enzymology, structure, and dynamics of acetohydroxy acid isomeroreductase. Acc Chem Res 34:399–408Google Scholar
  9. Fichera ME, Roos DS (1997) A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407–409Google Scholar
  10. Grellier P, Valentin A, Millerioux V, Schrevel J, Rigomier D (1994) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother 38:1144–12148Google Scholar
  11. Hecht S, Eisenreich W, Adam P, Amslinger S, Kis K, Bacher A, Arigoni D, Rohdich F (2001) Studies on the nonmevalonate pathway to terpenes: the role of the GcpE (IspG) protein. Proc Natl Acad Sci U S A 98:14837–14842Google Scholar
  12. Herz S, Wungsintaweekul J, Schuhr CA, Hecht S, Luttgen H, Sagner S, Fellermeier M, Eisenreich W, Zenk MH, Bacher A, Rohdich F (2000) Biosynthesis of terpenoids: YgbB protein converts 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate to 2C-methyl-D-erythritol 2,4-cyclodiphosphate. Proc Natl Acad Sci U S A 97:2486–2490Google Scholar
  13. Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M, Turbachova I, Eberl M, Zeidler J, Lichtenthaler HK, Soldati D, Beck E (1999) Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285:1573–1576Google Scholar
  14. Kamiya T, Hashimoto M, Hemmi K, Takeno H (1980) Hydroxyaminohydrocarbon-phosphonic acids. Fujisawa Pharmaceutical Company, US-patent no. 4206156Google Scholar
  15. Köhler S, Delwiche CF, Denny PW, Tilney LG, Webster P, Wilson RJ, Palmer JD, Roos DS (1997) A plastid of probable green algal origin in apicomplexan parasites. Science 275:1485–1489Google Scholar
  16. Koppisch AT, Fox DT, Blagg BS, Poulter CD (2002) E. coli MEP synthase: steady-state kinetic analysis and substrate binding. Biochemistry 41:236–243Google Scholar
  17. Kremsner PG (1990) Clindamycin in malaria treatment. J Antimicrob Chemother 25:9–14Google Scholar
  18. Kuemmerle HP, Murakawa T, Soneoka K, Konishi T (1985a) Fosmidomycin: a new phosphonic acid antibiotic. Part I: phase I tolerance studies. Int J Clin Pharmacol Ther Toxicol 23:515–20Google Scholar
  19. Kuemmerle HP, Murakawa T, Sakamoto H, Sato N, Konishi T, De Santis F (1985b) Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies. Int J Clin Pharmacol Ther Toxicol 23:521–528Google Scholar
  20. Kuzuyama T, Shizimu T, Takahashi S, Seto H (1998) Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway of isoprenoidbiosynthesis. Tetrahedron Lett 39:7913–7916Google Scholar
  21. Lell B, Ruangweerayut R, Wiesner J, Missinou MA, Schindler A, Baranek T, Hintz M, Hutchinson D, Jomaa H, Kremsner PG (2002) Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob Agents Chemother (in press)Google Scholar
  22. Mbaya B, Rigomier D, Edorh GG, Karst F, Schrevel J (1990) Isoprenoid metabolism in Plasmodium falciparum during the intraerythrocytic phase of malaria. Biochem Biophys Res Commun 173:849–854Google Scholar
  23. Missinou MA, Borrmann S, Schindler A, Issifou S Adegnika A, Matsiegui PB, Binder R, Lell B, Kremsner PG, Wiesner J, Baranek T, Jomaa H (2002) Fosmidomycin for malaria. Lancet (in press)Google Scholar
  24. Okuhara M, Kuroda Y, Goto T, Okamoto M, Terano H, Kohsaka M, Aoki H, Imanaka H (1980) Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. J Antibiot (Tokyo) 33:24–28.Google Scholar
  25. Parola P, Ranque S, Badiaga S, Niang M, Blin O, Charbit JJ, Delmont J, Brouqui P (2001) Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics. Antimicrob Agents Chemother 45:932–935Google Scholar
  26. Reichenberg A, Wiesner J, Weidemeyer C, Dreiseidler E, Sanderbrand S, Altincicek B, Beck E, Schlitzer M, Jomaa H (2001) Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg Med Chem Lett 11:833–835Google Scholar
  27. Reuter K, Sanderbrand S, Jomaa H, Wiesner J, Steinbrecher I, Beck E, Hintz M, Klebe G, Stubbs MT (2002) Crystal structure of 1-deoxy-D-xylulose-5-phosphate reductoisomerase, a crucial enzyme in the non-mevalonate pathway of isoprenoid biosynthesis. J Biol Chem 277:5378–5384Google Scholar
  28. Rohdich F, Eisenreich W, Wungsintaweekul J, Hecht S, Schuhr CA, Bacher A (2001) Biosynthesis of terpenoids. 2C-Methyl-D-erythritol 2,4-cyclodiphosphate synthase (IspF) from Plasmodium falciparum. Eur J Biochem 268:3190–3197Google Scholar
  29. Rohdich F, Hecht S, Gartner K, Adam P, Krieger C, Amslinger S, Arigoni D, Bacher A, Eisenreich W (2002) Studies on the nonmevalonate terpene biosynthetic pathway: metabolic role of IspH (LytB) protein. Proc Natl Acad Sci U S A 99:1158–1163Google Scholar
  30. Rohmer M (1999) The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat Prod Rep 16:565–574Google Scholar
  31. Rohmer M, Knani M, Simonin P, Sutter B, Sahm H (1993) Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem J 295:517–524Google Scholar
  32. Seto H, Wtanabe H, Furihata K (1996) Simultaneous operation of the mevalonate and non-mevalonate pathways in the biosynthesis of isopentenyl diphosphate in Streptomyces aeriouvifer. Tetrahedron Lett 37:7979–7982Google Scholar
  33. Skelton FS, Lunan KD, Folkers K, Schnell JV, Siddiqui WA, Geiman QM (1969) Biosynthesis of ubiquinones by malarial parasites. I. Isolation of [14C]ubiquinones from cultures of rhesus monkey blood infected with Plasmodium knowlesi. Biochemistry 8:1284–1287Google Scholar
  34. Tsuchiya T, Ishibashi K, Terakawa M, Nishiyama M, Itoh N, Noguchi H (1982) Pharmacokinetics and metabolism of fosmidomycin, a new phosphonic acid, in rats and dogs. Eur J Drug Metab Pharmacokinet 7:59–64Google Scholar
  35. Vial HJ, Philippot JR, Wallach DF (1984) A reevaluation of the status of cholesterol in erythrocytes infected by Plasmodium knowlesi and P. falciparum. Mol Biochem Parasitol 13:53–65Google Scholar
  36. Wiesner J, Hintz M, Altincicek B, Sanderbrand S, Weidemeyer C, Beck E, Jomaa H (2000) Plasmodium falciparum: detection of the deoxyxylulose 5-phosphate reductoisomerase activity. Exp Parasitol 96:182–186Google Scholar
  37. Wiesner J, Henschker D, Hutchinson DB, Beck E, Jomaa H (2002) In vitro and in vivo synergy of fosmidoymcin, a new antimalerial drug, with clindamycin. Antimicrob Agents Chemother 46:2889–2894Google Scholar
  38. Wunderlich F, Fiebig S, Vial H, Kleinig H (1991) Distinct lipid compositions of parasite and host cell plasma membranes from Plasmodium chabaudi-infected erythrocytes. Mol Biochem Parasitol 44:271–277Google Scholar
  39. Yajima S, Nonaka T, Kuzuyama T, Seto H, Ohsawa K (2002) Crystal structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase complexed with cofactors: implications of a flexible loop movement upon substrate binding. J Biochem (Tokyo) 131:313–317Google Scholar
  40. Zeidler J, Schwender J, Müller C, Wiesner J, Weidemeyer C, Beck E, Jomaa H, Lichtenthaler HK (1998) Inhibition of the non-mevalonate 1-deoxy-D-xylulose-5-phosphate pathway of plant isoprenoid biosynthesis by fosmidomycin. Z Naturforsch C 53:980–986.Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Jochen Wiesner
    • 1
  • Steffen Borrmann
    • 2
  • Hassan Jomaa
    • 1
  1. 1.Jomaa Pharmaka GmbH, Frankfurter Strasse 50, 35392 Gießen, Germany
  2. 2.Department of Parasitology, Institute of Tropical Medicine, University of Tübingen, 72074 Tübingen, Germany

Personalised recommendations